Posted by Clinical Lab Products | Jun 18, 2009 | Miscellaneous |
The Association for Molecular Pathology (AMP) today released the text of a comment letter it has provided to the Federal Coordinating Council for Comparative Effectiveness Research (CER) in which AMP sets forth its recommendations for priority areas on which to focus CER activities.
Read MorePosted by Clinical Lab Products | Jun 15, 2009 | Sexually Transmitted Diseases |
Quest Diagnostics Inc announced the availability of a new laboratory developed test designed to help physicians determine whether a patient with a history of HIV drug resistance will respond to the latest class of HIV antiretroviral therapies.
Read MorePosted by Clinical Lab Products | Jun 11, 2009 | Miscellaneous |
A new, easy-to-perform method for detecting both seasonal influenza A virus and the emerging H1N1 swine-derived influenza A virus in human clinical samples offers a fast, sensitive, and cost-effective diagnostic test that runs on standard laboratory equipment.
Read MorePosted by Clinical Lab Products | Jun 8, 2009 | Miscellaneous |
Cepheid and Instrumentation Laboratory today announced that Health Canada has issued Cepheid a medical device license for its Xpert HemosIL FII & FV test.
Read MorePosted by Clinical Lab Products | Jun 4, 2009 | Cancer, Molecular Diagnostics |
QIAGEN has announced the official launch of its next-generation CE-labelled assay for KRAS testing in colorectal cancer patients. In addition, the company gave an update on the pipeline of its regulated assay portfolio for personalized cancer treatment based upon the Pyrosequencing technology.
Read More